These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 6593107)

  • 1. Neuropeptide Y potentiates the effect of various vasoconstrictor agents on rabbit blood vessels.
    Edvinsson L; Ekblad E; Håkanson R; Wahlestedt C
    Br J Pharmacol; 1984 Oct; 83(2):519-25. PubMed ID: 6593107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms underlying pre- and postjunctional effects of neuropeptide Y in sympathetic vascular control.
    Pernow J; Saria A; Lundberg JM
    Acta Physiol Scand; 1986 Feb; 126(2):239-49. PubMed ID: 3010640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of neuropeptide Y-induced potentiation of noradrenaline-induced vasoconstriction by PP56 (D-myo-inositol 1,2,6-tris-phosphate).
    Adamsson M; Fallgren B; Edvinsson L
    Br J Pharmacol; 1992 Jan; 105(1):93-6. PubMed ID: 1596693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers.
    Ekblad E; Edvinsson L; Wahlestedt C; Uddman R; Håkanson R; Sundler F
    Regul Pept; 1984 Apr; 8(3):225-35. PubMed ID: 6379758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional involvement of an endothelium-derived contractile factor in the vasoactive actions of neuropeptide Y in bovine isolated retinal arteries.
    Prieto D; Simonsen U; Nyborg NC
    Br J Pharmacol; 1995 Nov; 116(6):2729-37. PubMed ID: 8590997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for different pre-and post-junctional receptors for neuropeptide Y and related peptides.
    Wahlestedt C; Yanaihara N; Håkanson R
    Regul Pept; 1986 Feb; 13(3-4):307-18. PubMed ID: 3010387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diminished contractile responses to neuropeptide Y of arteries from diabetic rabbits.
    Andersson D; Brunkwall J; Bergqvist D; Edvinsson L
    J Auton Nerv Syst; 1992 Mar; 37(3):215-22. PubMed ID: 1587998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innervation of human omental arteries and veins and vasomotor response to noradrenaline, neuropeptide Y, substance P and vasoactive intestinal peptide.
    Edvinsson L; Håkanson R; Steen S; Sundler F; Uddman R; Wahlestedt C
    Regul Pept; 1985 Sep; 12(1):67-79. PubMed ID: 2416012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide Y-induced potentiation of noradrenergic vasoconstriction in the human saphenous vein: involvement of endothelium generated thromboxane.
    Fabi F; Argiolas L; Ruvolo G; del Basso P
    Br J Pharmacol; 1998 May; 124(1):101-10. PubMed ID: 9630349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction: mode of action.
    Wahlestedt C; Edvinsson L; Ekblad E; Håkanson R
    J Pharmacol Exp Ther; 1985 Sep; 234(3):735-41. PubMed ID: 3928874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of noradrenaline and neuropeptide Y on rat mesenteric microvessel contraction.
    Chen H; Fetscher C; Schäfers RF; Wambach G; Philipp T; Michel MC
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):314-23. PubMed ID: 8692287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of neuropeptide Y on the sympathetic contraction of the rabbit central ear artery during cooling.
    García-Villalón AL; Padilla J; Fernández N; Monge L; Martínez MA; Gómez B; Diéguez G
    Pflugers Arch; 2000 Aug; 440(4):548-55. PubMed ID: 10958338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of neuropeptide Y-induced potentiation of noradrenaline-evoked vasoconstriction by D-myo-inositol-1.2.6-trisphosphate (PP56) in rabbit femoral arteries.
    Adamsson M; Edvinsson L
    Neuropeptides; 1991 May; 19(1):13-6. PubMed ID: 1891070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction by an intracellular calcium-dependent mechanism.
    Fallgren B; Arlock P; Edvinsson L
    J Auton Nerv Syst; 1993; 44(2-3):151-9. PubMed ID: 8227954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide Y induces and modulates vasoconstriction in intracranial and peripheral vessels of animals and man.
    Hanko JH; Törnebrandt K; Hardebo JE; Kåhrström J; Nobin A; Owman C
    J Auton Pharmacol; 1986 Jun; 6(2):117-24. PubMed ID: 3755439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropeptide Y in cerebrovascular function: comparison of membrane potential changes and vasomotor responses evoked by NPY and other vasoconstrictors in the guinea pig basilar artery.
    Fallgren B; Arlock P; Jansen I; Edvinsson L
    Neurosci Lett; 1990 Jun; 114(1):117-22. PubMed ID: 2381572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide Y potentiates contraction and inhibits relaxation of rabbit coronary arteries.
    Han C; Abel PW
    J Cardiovasc Pharmacol; 1987 Jun; 9(6):675-81. PubMed ID: 2442533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelium-independent potentiating effects of neuropeptide Y in the rat tail artery.
    Small DL; Bolzon BJ; Cheung DW
    Eur J Pharmacol; 1992 Jan; 210(2):131-6. PubMed ID: 1318205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characteristics of the canine cerebrovascular constriction produced by neuropeptide Y.
    Uneyama H; Tanaka Y; Iwata S; Ishiguro T; Nakayama K
    Biol Pharm Bull; 1995 Apr; 18(4):501-6. PubMed ID: 7655416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226.
    Cortés V; Donoso MV; Brown N; Fanjul R; López C; Fournier A; Huidobro-Toro JP
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1313-22. PubMed ID: 10336522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.